Evidence map›Paper›PMID 28782982›Full record

ArticleExperimental and clinical psychopharmacology2017

Sleep continuity, architecture and quality among treatment-seeking cannabis users: An in-home, unattended polysomnographic study.

Lauren R Pacek, Evan S Herrmann, Michael T Smith, Ryan Vandrey

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01685073 (The Role of Sleep in the Treatment of Cannabis Use Disorders), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01685073 phase2 / phase3completednot on this map

The Role of Sleep in the Treatment of Cannabis Use Disorders

TypeinterventionalSponsorJohns Hopkins UniversityRan2012 to 2018Enrolled127ConditionsDrug AddictionArmsZolpidem extended-release, MET/CBT
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The impact of cannabis use proximal to sleep and cannabinoid metabolites on sleep architecture.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Article
  12. Review
  13. Cannabis and sleep disorders: not ready for prime time? A qualitative scoping review.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  14. Article
  15. Review
  16. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  17. Article
  18. Article
  19. Sleep Management Among Patients with Substance Use Disorders.The Medical clinics of North America · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lauren R PacekDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine.
Evan S HerrmannDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University.
Michael T SmithDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University.
Ryan VandreyDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University.
Johns Hopkins University · USDuke University · US

Funding

HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSET32DA007209 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Eric C. Strain, Elise M Weerts · 1985 to 2026
$12.9M
Role of Sleep in the Treatment of Cannabis DependenceU01DA031784 · NIDA · JOHNS HOPKINS UNIVERSITY · PI VANDREY, RYAN G · 2012 to 2016
$3.2M
NIDA NIH HHS T32 DA007209NIDA NIH HHS U01 DA031784
6 · The paper itself

Abstract

The objective of the study was to describe self-report and objectively measured sleep characteristics of adult treatment-seeking cannabis users. Study participants (n = 87) were adults who were screened for a 12-week outpatient cannabis treatment research program in Baltimore, MD. Participants completed objective and self-report measures of sleep quality. Data were analyzed for the sample overall and after stratifying by sex (54 men, 33 women). Participants were primarily urban, socioeconomically disadvantaged African Americans. Participants were frequent, heavy cannabis users; among a subset of participants assessed, 76.7% used cannabis on the day/night of the assessment. Participants had low rates of other substance abuse and of psychiatric comorbidities. Polysomnography indicated 19.5% of participants received the recommended 7 to 9 hr of sleep, with women averaging more sleep than men. One third (31.0%) had sleep latencies >30 min, one half spent >30 min awake after sleep onset, and more than one half of the sample (55.2%) had sleep efficiency scores of <85%. Most participants met criteria for subthreshold (36.8%) or clinical insomnia (25.3%) on the Insomnia Severity Index, 77.0% had scores of >5 on the Pittsburgh Sleep Quality Index. Most had average scores on the Dysfunctional Beliefs and Attitudes About Sleep (DBAS) questionnaire (M = 51.1, SD = 18.8) that were higher than average among clinical insomnia patients. Women had higher DBAS scores than men. Most participants exhibited characteristics of disordered sleep, and sex differences were observed on polysomnography and self-report measures. Findings extend prior research concerning the association between cannabis use and disordered sleep. Data presented in this article come from Clinical Trial NCT01685073. (PsycINFO Database Record

Indexed as

AdultAmbulatory CareBaltimoreFemaleHumansMaleMarijuana AbuseOutpatientsPolysomnographySelf ReportSex FactorsSleepSleep Initiation and Maintenance DisordersSurveys and QuestionnairesYoung Adult

Identifiers

PMID28782982
PMCPMC6309181
OpenAlexW2742507520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.